The FDA is alerting healthcare professionals to this new dosing regimen and also warning about the potential for severe drug interactions when patients take colchicine.

• FDA提醒医疗卫生专业人士使用上述新的剂量方案，并警告当患者使用秋水仙碱时可能存在严重药物相互作用。